Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT00005007Phase 2/3Completed
Etanercept for Wegener's Granulomatosis
Wegener's Granulomatosis
Principalinvestigator
NCT00104299Phase 2/3Completed
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Microscopic PolyangiitisVasculitisWegener's Granulomatosis
Studychair

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Johns Hopkins University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ulrich Specks, MD

Mayo Clinic

Moderately Similar
3 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic PolyangiitisVasculitis

Worked with same sponsors:

Genentech, Inc.Immune Tolerance Network (ITN)+1 more
Collaborated on 1 trial
Similarity Score34%

Peter A Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisVasculitisMicroscopic Polyangiitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Similarity Score30%

Peter Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
4 trials

Shared therapeutic areas:

Microscopic PolyangiitisVasculitisGranulomatosis with Polyangiitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Similarity Score30%

Peter A. Merkel, MD, MPH

University of Pennsylvania

Moderately Similar
10 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic PolyangiitisVasculitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Similarity Score30%

Megan Clowse, MD, MPH

Duke University

Moderately Similar
2 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic PolyangiitisVasculitis
Similarity Score30%

Loïc Guillevin, MD,PhD

Assistance Publique - Hôpitaux de Paris

Moderately Similar
3 trials

Shared therapeutic areas:

Microscopic PolyangiitisVasculitisGranulomatosis with Polyangiitis
Similarity Score30%

Amanda M. Terry, MA

University of South Florida College of Medicine

Related
2 trials

Shared therapeutic areas:

Microscopic PolyangiitisGranulomatosis with Polyangiitis
Similarity Score20%

Peter A. Merkel, MD, MPH

Boston University

Related
2 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisMicroscopic Polyangiitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Similarity Score20%

Peter C. Grayson, MD

Boston University

Related
2 trials

Shared therapeutic areas:

Microscopic PolyangiitisGranulomatosis with Polyangiitis
Similarity Score20%

Jeffrey P Krischer, PhD

University of South Florida

Related
3 trials

Shared therapeutic areas:

Granulomatosis with PolyangiitisVasculitis

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00005007Phase 2/3PrincipalInvestigator

Etanercept for Wegener's Granulomatosis

Wegener's Granulomatosis
Completed
NCT00104299Phase 2/3StudyChair

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Microscopic PolyangiitisVasculitisWegener's Granulomatosis
Completed

All 2 trials loaded